Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: Role of IgA in HIV-1 Protection |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2013-01-29 |
| Study Made Public: | 2013-08-16 |
Title
Purified IgA For Neutralization
Description
CAVD 409 is an immunogenicity study to isolate and characterize monoclonal antibodies from RV144, RV305, and RV306 human clinical trial subjects.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.